Skip to Main Content
Yale Institute for Global Health
Yale Home

INFORMATION FOR

Michael S. Leapman, MD, MHS

Associate Professor of Urology
DownloadHi-Res Photo

Additional Titles

Clinical Program Leader, Prostate & Urologic Cancers Program, Yale Cancer Center

Assistant Professor, Chronic Disease Epidemiology

Contact Info

michael.leapman@yale.edu

Urology

PO Box 208058

New Haven, CT 06520-8058

United States

About

Titles

Associate Professor of Urology

Clinical Program Leader, Prostate & Urologic Cancers Program, Yale Cancer Center; Assistant Professor, Chronic Disease Epidemiology

Biography

Clinical interests: Prostate cancer: low-risk prostate cancer, active surveillance, nerve-sparing robotic prostatectomy, focal therapy, high-risk disease, pelvic lymph node dissection, imaging, risk stratification; molecular imaging; PSMA; focal therapy; bladder cancer: intravesical therapy, TURBT, radical cystectomy with urinary diversion, continent urinary diversion, neobladder, ileal conduit. Kidney cancer: laparoscopic radical nephrectomy, laparoscopic partial nephrectomy, robotic partial nephrectomy, open radical nephrectomy, open partial nephrectomy. Testicular cancer. Upper tract urothelial carcinoma: laparoscopic, open nephroureterectomy, ureterectomy Watch a video with Dr. Michael Leapman >>

Michael Leapman, MD was drawn to the field of urology for the opportunity to care for patients with urologic cancers. He aims, above all, to deliver the highest level of care possible with the utmost consideration and compassion for the impact that cancer places on patients, as well as their families, friends and communities.

Dr. Leapman graduated from Cornell University where he majored in Neurobiology and Behavior, and received his medical school degree from the University of Maryland in Baltimore. He completed his General Surgery and Urology training at the Mount Sinai Hospital in New York, NY. Subsequently, he completed a urologic oncology fellowship at the University of California San Francisco (UCSF) accredited by the Society of Urologic Oncology. He joined the faculty at the Yale University School of Medicine and Yale Cancer Center in 2016, specializing in urologic oncology with a joint appointment at the West Haven Veterans Affairs Medical Center.

Appointments

Other Departments & Organizations

Education & Training

MHS
Yale University (2022)
Fellowship
University of California San Francisco (2016)
Residency
Mount Sinai Medical Center (2014)
Internship
Mount Sinai Medical Center (2010)
MD
University of Maryland School of Medicine (2009)
BA
Cornell University (2005)

Research

Overview

Medical Subject Headings (MeSH)

Delivery of Health Care; Health Services Research; Kidney Diseases; Prostatic Neoplasms; Ureteral Diseases; Urinary Bladder Diseases; Urologic Neoplasms

Research at a Glance

Yale Co-Authors

Frequent collaborators of Michael S. Leapman's published research.

Publications

2024

See All Publications

Clinical Trials

Current Trials

Academic Achievements & Community Involvement

  • honor

    John N. Forrest Jr. Prize for Mentorship in Student Research

    Yale School of Medicine Award
  • honor

    Best Poster

    International AwardEuropean School of Oncology, Conference on Active Surveillance
  • honor

    Merit Award

    National AwardConquer Cancer Foundation of the American Society of Clinical Oncology
  • honor

    First Place Essay, History Section

    Regional AwardAmerican Urological Association Western Section
  • honor

    Outstanding Abstract Selected for Oral Presentation

    Regional AwardUniversity of California San Francisco
See All Achievements

Clinical Care

Overview

Michael S. Leapman, MD, who specializes in prostate, bladder, testicular and kidney cancers, loves his work as a urologic oncologist.

“Every day, I have the ability to make a difference in a patient's life,” says Dr. Leapman. “It's a tremendous honor and responsibility, and it's very rewarding.”

A member of Yale Cancer Center, he sees patients at Smilow Cancer Hospital and the West Haven Veteran’s Administration. An assistant professor of urology at Yale School of Medicine, he studies the best treatments for prostate cancer and how gene expression signatures can predict the aggressiveness of this cancer.

“Hearing the emotionally wrought words ‘it’s cancer’ is extremely difficult to navigate,” he says. “So that's one of the issues that we are sensitive to, and continue to strive to improve.”

The patient-physician bond is essential in helping patients with prostate cancer, for example, to choose which kind of treatment is best: surgery, radiation therapy or active surveillance, an ongoing monitoring of what can be a slow-progressing disease.

“It really is a very special relationship between a urologist and a patient. I have found that the team at Yale is 100 percent invested in the outcomes of our patients, and we stand out by seeking to understand their concerns, goals by being there for them every step of the way.”

Clinical Specialties

Urology; Urologic Oncology

Fact Sheets

See All Fact Sheets On Yale Medicine

Board Certifications

  • Urology

    Certification Organization
    AB of Urology
    Original Certification Date
    2018

Yale Medicine News

See All News On Yale Medicine

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Get In Touch

Contacts

Email
Appointment Number
Clinical Inquiry Number
Mailing Address

Urology

PO Box 208058

New Haven, CT 06520-8058

United States

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    See Patient Care Locations